Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
IDYA IDEAYA Biosciences Inc
- Stocks
- Healthcare
- NASDAQ: IDYA
Price (delayed)
$17.42
Market cap
$1.53B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.65
Enterprise value
$1.42B
IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates
Highlights
IDEAYA Biosciences's equity has increased by 9% YoY but it has decreased by 3.3% QoQ
The net income has plunged by 138% YoY and by 12% from the previous quarter
The EPS has dropped by 82% year-on-year and by 9% since the previous quarter
Key stats
What are the main financial stats of IDYA
Market
Valuations
Earnings
Shares outstanding
87.58M
Market cap
$1.53B
Enterprise value
$1.42B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.49
Price to sales (P/S)
219.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
202.98
Revenue
$7M
Gross profit
$7M
Operating income
-$360.35M
Net income
-$307.08M
EBIT
-$307.08M
EBITDA
-$303.2M
Free cash flow
-$267.98M
Per share
Balance sheet
Liquidity
EPS
-$3.65
EPS diluted
-$3.65
Free cash flow per share
-$3.03
Book value per share
$11.7
Revenue per share
$0.08
TBVPS
$12.46
Total assets
$1.1B
Total liabilities
$76.51M
Debt
$25.97M
Equity
$1.02B
Working capital
$657.03M
Debt to equity
0.03
Current ratio
13.92
Quick ratio
13.64
Net debt/EBITDA
0.35
Margins
Efficiency
Dividend
EBITDA margin
-4,331.4%
Gross margin
100%
Net margin
-4,386.9%
Operating margin
-5,147.8%
Return on assets
-27.7%
Return on equity
-29.3%
Return on invested capital
-34.9%
Return on capital employed
-29.3%
Return on sales
-4,386.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IDYA stock price
How has the IDEAYA Biosciences stock price performed over time
Intraday
-4.18%
1 week
-16.77%
1 month
10.39%
1 year
-57.14%
YTD
-32.22%
QTD
6.35%
Financial performance
How have IDEAYA Biosciences's revenue and profit performed over time
Revenue
$7M
Gross profit
$7M
Operating income
-$360.35M
Net income
-$307.08M
Gross margin
100%
Net margin
-4,386.9%
The net income has plunged by 138% YoY and by 12% from the previous quarter
IDYA's operating income has dropped by 126% year-on-year and by 10% since the previous quarter
The revenue has dropped by 55% year-on-year
The company's gross profit has shrunk by 55% YoY
Price vs fundamentals
How does IDYA's price correlate with its fundamentals
Growth
What is IDEAYA Biosciences's growth rate over time
Valuation
What is IDEAYA Biosciences stock price valuation
P/E
N/A
P/B
1.49
P/S
219.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
202.98
The EPS has dropped by 82% year-on-year and by 9% since the previous quarter
The stock's P/B is 38% below its 5-year quarterly average of 2.4 and 32% below its last 4 quarters average of 2.2
IDEAYA Biosciences's equity has increased by 9% YoY but it has decreased by 3.3% QoQ
The stock's price to sales (P/S) is 102% more than its 5-year quarterly average of 108.6 but 39% less than its last 4 quarters average of 357.9
The revenue has dropped by 55% year-on-year
Efficiency
How efficient is IDEAYA Biosciences business performance
The company's return on equity fell by 46% YoY and by 10% QoQ
The ROA has contracted by 44% YoY and by 9% from the previous quarter
IDYA's ROIC is down by 39% YoY and by 8% from the previous quarter
The return on sales has declined by 12% since the previous quarter
Dividends
What is IDYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IDYA.
Financial health
How did IDEAYA Biosciences financials performed over time
IDEAYA Biosciences's total liabilities has soared by 192% YoY and by 18% from the previous quarter
The quick ratio has plunged by 51% YoY and by 7% from the previous quarter
The company's debt is 97% lower than its equity
IDEAYA Biosciences's debt to equity has surged by 50% QoQ
The company's debt rose by 35% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.